NSW Health Pathology

Site

Molecular Medicine Laboratory

Accreditation No.

2114

Site No.

24908

Date of Accreditation

26 Mar 2020

Address

Building 20A, 2 Hospital Road
Concord Repatriation Hospital, NSW 2139
Australia

cs.nsw.gov.au

Contact

Ms Wafa Jeha P: +61 (02) 97677029

Availability

Services available to external clients

Supervision

B (Branch)

Scope of Accreditation

Print scopes
Molecular Medicine Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

24 Jan 2024

Service Product Determinant
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies Serum Anti-muscle specific kinase antibodies (MuSK)
Anti-acetylcholine receptor antibodies (AChR)
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood; Extracted DNA Charcot-Marie-Tooth neuropathy; Dentatorubral-pallidoluysian atrophy (Naito-Oyanagi disease); Facioscapulohumeral muscular dystrophy; Friedreich's ataxia (FRDA, FA); Hereditary spastic paraplegia; Kennedy's disease (spinal and bulbar muscular atrophy); Motor neurone disease; Myotonic dystrophy; Oculopharyngeal muscular dystrophy; Parkinson's disease; Spinocerebellar ataxia
Molecular genetics - DNA extraction Amniotic fluid; Blood; Buccal swabs; Chorionic villus tissue DNA storage for future analyses; Viable DNA; Viable DNA for sequencing
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood; Extracted DNA Charcot-Marie-Tooth neuropathy; Friedreich's ataxia (FRDA, FA); Hereditary sensory neuropathy; Hereditary spastic paraplegia; Parkinson's disease
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted panels for inherited (germline) DNA/RNA changes Blood; Extracted DNA Charcot-Marie-Tooth neuropathy; Dentatorubral-pallidoluysian atrophy (Naito-Oyanagi disease); Facioscapulohumeral muscular dystrophy; Familial motor neurone disease - Amyotrophic lateral sclerosis (ALS); Friedreich's ataxia (FRDA, FA); Hereditary spastic paraplegia; Oculopharyngeal muscular dystrophy; Spinocerebellar ataxia
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes Blood; Extracted DNA Charcot-Marie-Tooth neuropathy; Dentatorubral-pallidoluysian atrophy (Naito-Oyanagi disease); Facioscapulohumeral muscular dystrophy; Friedreich's ataxia (FRDA, FA); Hereditary sensory neuropathy; Hereditary spastic paraplegia; Kennedy's disease (spinal and bulbar muscular atrophy); Motor neurone disease; Myotonic dystrophy; Oculopharyngeal muscular dystrophy; Spinocerebellar ataxia
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changesExcludes sequencing Blood; Extracted DNA Ataxia; Congenital myasthenic syndrome; Dystonia; Hereditary spastic paraplegia; Motor neurone disease; Neurodevelopmental delay; Peripheral neuropathy
Molecular genetics - Predictive genetic testing - Targeted genes Blood Charcot-Marie-Tooth neuropathy; Familial motor neurone disease - Amyotrophic lateral sclerosis (ALS); Hereditary sensory neuropathy; Hereditary spastic paraplegia
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood Charcot-Marie-Tooth neuropathy; Dentatorubral-pallidoluysian atrophy (Naito-Oyanagi disease); Facioscapulohumeral muscular dystrophy; Familial motor neurone disease - Amyotrophic lateral sclerosis (ALS); Friedreich's ataxia (FRDA, FA); Hereditary sensory neuropathy; Hereditary spastic paraplegia; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Oculopharyngeal muscular dystrophy; Spinocerebellar ataxia
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood; Extracted DNA Charcot-Marie-Tooth neuropathy; Dentatorubral-pallidoluysian atrophy (Naito-Oyanagi disease); Facioscapulohumeral muscular dystrophy; Friedreich's ataxia (FRDA, FA); Hereditary sensory neuropathy; Hereditary spastic paraplegia; Kennedy's disease (spinal and bulbar muscular atrophy); Motor neurone disease; Myotonic dystrophy; Oculopharyngeal muscular dystrophy; Spinocerebellar ataxia

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.